CompletedNot Applicable

Study of the Analytical Performance of ALLEGRO™ Instrument

United Kingdom50 participantsStarted 2017-06-01

Plain-language summary

A new analyser has been developed (Allegro™) which allows the tests to be undertaken at the clinic, with the results available in a few minutes. This means that patients can get immediate feedback and that the doctors/nurses can adjust treatment before the patient leaves the clinic. It is obviously important that this analyser performs to a similar degree of accuracy to the laboratory analyses.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diabetes patients attending Altnagelvin Area Hospital Clinics or primary care in Western Trust area aged 18-80 years of age Exclusion Criteria: * Patients who are less than 18 years or over 80 years of age

What they're measuring

Analytical verification of Allegro - HbA1c comparison

Timeframe: 10 minutes

Analytical verification of Allegro - Cholesterol comparison

Timeframe: 10 minutes

Analytical verification of Allegro - HDL comparison

Timeframe: 10 minutes

Analytical verification of Allegro - Triglycerides comparison

Timeframe: 10 minutes

Analytical verification of Allegro - Glucose comparison

Timeframe: 10 minutes

Analytical verification of Allegro - Creatinine comparison

Timeframe: 10 minutes

Analytical verification of Allegro - Urine creatinine comparison

Timeframe: 10 minutes

Analytical verification of Allegro - Urine Albumin comparison

Timeframe: 10 minutes

Trial details

NCT IDNCT04035044

SponsorNova Biomedical

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2018-05-31

View on ClinicalTrials.gov More Diabetes trials